Summary
The Laboratory for Cell Stress & Immunity at KU Leuven is offering a PhD position focused on developing innovative immunotherapy solutions for immuno-resistant tumors. This research position aims to translate fundamental insights into practical approaches that can be implemented in clinical settings.
Designation
PhD Candidate in Immuno-Oncology
| Field | Details |
|---|---|
| Research Area | Cancer Immunology, Immunotherapy, Antibody Engineering |
| Location | KU Leuven, Belgium |
| Eligibility | Master’s degree in Biomedical/Pharmaceutical Sciences (or equivalent) |
| Job Description | High-quality experimental research in antibody engineering and tumor immunology; presentation and collaboration responsibilities. |
| How to Apply | Applications can be submitted via the online application tool on the KU Leuven website. |
| Last Date to Apply | July 8, 2026 (23:59 CET) |
Research Area
The research will encompass:
- Cancer immunology & immunotherapy
- Immune cell biology
- Computational immunology
- Multi-omics biomarkers for clinical immuno-oncology
Eligibility/Qualification
- Hold a master’s degree in biomedical or pharmaceutical sciences (or related disciplines) by July 2026.
- Experience with techniques such as cell culture, basic animal handling, and data analysis is preferred.
- Strong knowledge in immunology, oncology, and cancer biology.
Job Description
PhD candidates will have the following responsibilities:
- Conduct experiments related to antibody engineering and in vivo tumor immunology.
- Present research findings in seminars and conferences.
- Collaborate with other researchers and potentially supervise master’s thesis projects.
How to Apply
Interested candidates should apply online through the KU Leuven application portal. Early applications are encouraged as they will be considered continuously.
Last Date to Apply
July 8, 2026, at 23:59 CET
